QTIAPX:NASDAQ
Thrivent International Allocation Portfolio – QTIAPX Fund Overview
| Last Price | Today's Change | 52-Week Range | Trading Volume |
|---|
| -- | -- (--%) | -- - -- | -- |
Market data as of --. Quotes are delayed by at least 15 min.
Overview - QTIAPX
The investment seeks long-term capital growth.
The fund invests primarily in equity securities of issuers throughout the world. It seeks to diversify its portfolio broadly among developed and emerging countries and among multiple asset classes. The fund normally invests at least 40% of its net assets in foreign assets. It generally invests 0-80% of assets in international large- and mid-cap equity, 0-30% in international small-cap equity, 0-25% in emerging-markets equities, and 0-10% in U.S. securities.
Growth of $10,000 (10 Years)
| Total Return | 3.27% |
|---|
| Yield (Trailing 12 Mo.) | 3.01% |
|---|
| Expense Ratio | 0.75% |
|---|
| Front Load | None |
|---|
| Deferred Load | None |
|---|
| Minimum Investment | $0.00 |
|---|
| Management Tenure | 9 Years |
|---|
| Fund Inception | 04/30/2008 |
|---|
Trailing Total Returns - QTIAPX
as of 02/28/2025
| Timeframe | QTIAPX | S&P 500 | Foreign Large Blend |
|---|
| 1 Month | 2.05% | -5.63% | 2.50% |
|---|
| 3 Month | 3.26% | -4.27% | 4.46% |
|---|
| Year-to-Date | 6.24% | -4.27% | 7.29% |
|---|
| 1 Year | 8.58% | 8.25% | 9.36% |
|---|
| 3 Year | 4.99% | 9.06% | 5.61% |
|---|
| 5 Year | 7.25% | 18.59% | 7.89% |
|---|
| 10 Year | 4.54% | 12.50% | 4.79% |
|---|
| Since Inception | 3.27% | 10.98% | -- |
|---|
Sector Allocation - QTIAPX
as of 02/28/2025
| Basic Materials | | 8.07% |
|---|
| Consumer Cyclical | | 12.05% |
|---|
| Financial Services | | 22.72% |
|---|
| Real Estate | | 1.73% |
|---|
| Consumer Defensive | | 5.42% |
|---|
| Healthcare | | 9.79% |
|---|
| Utilities | | 2.74% |
|---|
| Communication Services | | 5.02% |
|---|
| Energy | | 4.82% |
|---|
| Industrials | | 15.70% |
|---|
| Technology | | 11.95% |
|---|
Asset Allocation - QTIAPX
as of 02/28/2025
| By Percent | Short | 0% | Long | Net |
|---|
| Stock | 0.00 | | | 0.10 | 0.10 |
|---|
| Bond | 0.00 | | | 0.00 | 0.00 |
|---|
| Other | 0.00 | | | 0.02 | 0.02 |
|---|
| Foreign Stock | 0.00 | | | 101.78 | 101.78 |
|---|
| Foreign Bond | 0.00 | | | 0.00 | 0.00 |
|---|
| Total | 0.00 | | | 101.90 | 101.90 |
|---|
| Cash | 3.88 | | | 1.98 | -1.90 |
|---|
| Total Net Assets | $1.47B |
|---|
| Total Stock Holdings | 888 |
|---|
| Total Bond Holdings | 0 |
|---|
Top Ten Holdings - QTIAPX
as of 02/28/2025
| Company | YTD Return | % of Assets |
|---|
| MSCI EAFE Index Future Mar 25 | -- | 3.55% |
|---|
| Shell PLC | -- | 2.18% |
|---|
| Novartis AG Registered Shares | -- | 1.69% |
|---|
| Allianz SE | -- | 1.69% |
|---|
| ASML Holding NV | -- | 1.56% |
|---|
| Givaudan SA | -- | 1.48% |
|---|
| AstraZeneca PLC | -- | 1.46% |
|---|
| Roche Holding AG | -- | 1.43% |
|---|
| Ferrari NV | -- | 1.40% |
|---|
| Novo Nordisk AS Class B | -- | 1.25% |
|---|
Valuation & Growth - QTIAPX
as of 02/28/2025
| Valuation | QTIAPX | Category Range |
|---|
| Price/Earnings | 14.63 | |
|---|
| Price/Book | 1.75 | |
|---|
| Price/Sales | 1.34 | |
|---|
| Price/Cash Flow | 9.14 | |
|---|
| Dividend Yield | 3.26 | |
|---|
| LT Earnings | 9.06 | |
|---|
| Historical Earnings | 17.39 | |
|---|
| Sales Growth | 1.15 | |
|---|
| Cash-Flow Growth | 8.37 | |
|---|
| Book-Value Growth | -2.21 | |
|---|
